This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by van Egmond, M. Articles by van de Winkel, J. G. J. Search for Related Content PubMed PubMed Citation Articles by van Egmond, M. Articles by van de Winkel, J. G. J.

Enhancement of Polymorphonuclear Cell-mediated Tumor Cell Killing on Simultaneous Engagement of FcRI (CD64) and FcRI (CD89)¹

Departments of Cell Biology/Immunology and Surgical Oncology, Vrije Universiteit, Amsterdam, the Netherlands [M. v. E.]; Department of Immunology [A. B. v. S., H. V., G. H., J. G. J. v. d. W.], Medarex Europe [A. B. v. S.], and Genmab [J. G. J. v. d. W.], University Medical Center Utrecht, Utrecht, the Netherlands; and Department of Pathology, Faculty of Veterinary Medicine, Utrecht, the Netherlands [E. v. G.]

Antibodies can efficiently induce antitumor responses via recruitment of Fc receptor-bearing cytotoxic cells. Polymorphonuclear (PMN) cells represent attractive effector cells for antibody-directed immunotherapy. This, because activated PMN cells coexpress the class I receptors for IgG (FcRI, CD64) and IgA (FcRI, CD89), which are potent cytotoxic trigger molecules. Both receptors, however, require the FcR chain for signaling. In this study, we show that FcRI and FcRI can trigger function independently of one another and do not cross-compete for the FcR chain. FcRI proved more efficient in initiating early signaling events and effector functions, such as redirected tumor cell killing and generation of superoxide. In addition, simultaneous engagement of FcRI and FcRI resulted in enhanced tumor cell lysis. These data support the development of concepts in which both FcRI and FcRI on PMN cells are targeted for tumor therapy.

This article has been cited by other articles:

				M. A. Otten, J. H. W. Leusen, E. Rudolph, J. A. van der Linden, R. H. J. Beelen, J. G. J. van de Winkel, and M. van Egmond FcR {gamma}-Chain Dependent Signaling in Immature Neutrophils Is Mediated by Fc{alpha}RI, but Not by Fc{gamma}RI J. Immunol., September 1, 2007; 179(5): 2918 - 2924. [Abstract] [Full Text] [PDF]

				A. Jafarshad, M. H. Dziegiel, R. Lundquist, L. K. Nielsen, S. Singh, and P. L. Druilhe A Novel Antibody-Dependent Cellular Cytotoxicity Mechanism Involved in Defense against Malaria Requires Costimulation of Monocytes Fc{gamma}RII and Fc{gamma}RIII J. Immunol., March 1, 2007; 178(5): 3099 - 3106. [Abstract] [Full Text] [PDF]

				J. E. Bakema, S. de Haij, C. F. den Hartog-Jager, J. Bakker, G. Vidarsson, M. van Egmond, J. G. J. van de Winkel, and J. H. W. Leusen Signaling through Mutants of the IgA Receptor CD89 and Consequences for Fc Receptor {gamma}-Chain Interaction J. Immunol., March 15, 2006; 176(6): 3603 - 3610. [Abstract] [Full Text] [PDF]

				P. Martin, R. Wallich, J. Pardo, A. Mullbacher, M. Munder, M. Modolell, and M. M. Simon Quiescent and activated mouse granulocytes do not express granzyme A and B or perforin: similarities or differences with human polymorphonuclear leukocytes? Blood, October 15, 2005; 106(8): 2871 - 2878. [Abstract] [Full Text] [PDF]

				M. A. Otten, E. Rudolph, M. Dechant, C. W. Tuk, R. M. Reijmers, R. H. J. Beelen, J. G. J. van de Winkel, and M. van Egmond Immature Neutrophils Mediate Tumor Cell Killing via IgA but Not IgG Fc Receptors J. Immunol., May 1, 2005; 174(9): 5472 - 5480. [Abstract] [Full Text] [PDF]

				J. Schettini, G. Salamone, A. Trevani, S. Raiden, R. Gamberale, M. Vermeulen, M. Giordano, and J. R. Geffner Stimulation of neutrophil apoptosis by immobilized IgA J. Leukoc. Biol., October 1, 2002; 72(4): 685 - 691. [Abstract] [Full Text] [PDF]